Special Issue "Novel Strategies to Control Antimicrobial Resistance"
Deadline for manuscript submissions: closed (31 May 2020) | Viewed by 49287
Interests: microbiology; human defensins; Helicobacter pylori; microbiome; genomics; epigenetics; cell biology; cancer biology; gene regulation; antimicrobial peptides
Special Issues, Collections and Topics in MDPI journals
Antimicrobial resistance is today one of the most important public health problems and is destined to become one of the main health challenges of the coming decades.
The increasing incidence of infections with multiresistant micro-organisms (multi-drug-resistant organisms, MDRO) dramatically reduces the therapeutic equipment available to the doctor, leading to an increase in the complexity of treatments with an increase in morbidity, mortality, and costs associated with healthcare and generates a social alarm that is difficult to manage.
The advancement of effective means of control and rapid detection is essential for the treatment and prevention of multiple bacterial infections resistant to antibiotics.
Many control systems, including combination therapy, phages, and systems based on the antibiotic resistance mechanism (efflux pump and beta-lactamase inhibitors) have been designed to improve antibacterial activity against multiple antibiotic-resistant pathogens. Different approaches have been developed for rapid, selective, and sensitive detection for multiple antibiotic-resistant pathogens, including nucleic acid probes, molecular-based techniques, chemical methods, and physical methods.
In this Special Issue of Antibiotics, we invite you to send contributions concerning any aspects related, but not limited to prevention, new therapeutic agents, drug discovery, diagnostics, and drug resistance.
Furthermore, studies based on antibiotic mechanisms and any biological activity related to the therapeutic potential of antimicrobial peptides, including direct and indirect modes of action, are welcome for this Special Issue.
Dr. Raffaela Pero
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Antimicrobial resistance
- Antibiotic mechanisms
- Antibiotic activity
- Combination therapy
- Phages therapy
- Multi-drug-resistant organisms (MDRO)
- Drug discovery
- Antimicrobial peptides
- Diagnostics resistance